Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,252 public trials 1,192 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

NCT00283244

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Summit Cancer Care Savannah, Georgia, United States
  • Evanston Hospital Evanston, Illinois, United States
  • Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
View Trial Details
Completed

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer

NCT01999673

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Peregrine Pharmaceuticals Investigational Site Huntsville, Alabama, United States
  • Peregrine Pharmaceuticals Investigational Site Chandler, Arizona, United States
  • Peregrine Pharmaceuticals Investigational Site Glendale, Arizona, United States
  • Peregrine Pharmaceuticals Investigational Site Greenbrae, California, United States
View all 161 locations
View Trial Details
Completed

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

NCT00899028

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

NCT01138163

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • South Bay Hematology Oncology Campbell, California, United States
  • Medical Oncology Care Associates Orange, California, United States
  • American Institute of Research Whittier, California, United States
View all 53 locations
View Trial Details
Completed

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

NCT01160601

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Baptist Clinical Research Jonesboro, Arkansas, United States
  • American Institute of Research Whittier, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 40 locations
View Trial Details
Completed

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

NCT03117335

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Bengbu medical college affiliated hospital Bengbu, Anhui, China
  • The first affiliated hospital, anhui medical university Hefei, Anhui, China
  • The second affiliated hospital, anhui medical university Hefei, Anhui, China
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
View all 37 locations
View Trial Details
Completed

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

NCT00622193

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Osler Medical Melbourne, Florida, United States
  • Augusta Oncology Associates Augusta, Georgia, United States
  • South Georgia Medical Center Valdosta, Georgia, United States
View all 33 locations
View Trial Details
Completed

A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations

NCT01153984

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • County Hospital Alba; Oncology Alba Iulia, Romania
  • Institut of Oncology Al. Trestioreanu Bucharest; Oncology Bucharest, Romania
  • Institute Of Oncology Bucharest; Medical Oncology Bucharest, Romania
  • Spitalul de Boli Cronice Sf. Luca Bucharest, Romania
View Trial Details

Related conditions